AIM ImmunoTech Inc. — Director's Dealing 2012

Aug 10, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2012-08-08

Reporting Person: KIANI IRAJ EGHBAL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-08-08	Common Stock	J	368345	$0.26	Acquired	630886	Direct

Footnotes

F1: Shares received in payment for services as a Director of Hemispherx